References
- Kuijpers MH, de Jong W. Spontaneous hypertension in the fawn-hooded rat: a cardiovascular disease model. J Hypertens Suppl 1986;4:S41–44.
- Kuijpers MH, Provoost AP, de Jong W. Development of hypertension and proteinuria with age in fawn-hooded rats. Clin Exp Pharmacol Physiol 1986;13:201–9.
- De Keijzer MH, Provoost AP, Molenaar JC. Glomerular hyperfiltration in hypertensive Fawn-Hooded rats. Renal Physiol Biochem 1988;11:103–8.
- Simons JL, Provoost AP, Anderson S, et al. Pathogenesis of glomerular injury in the fawn-hooded rat: early glomerular capillary hypertension predicts glomerular sclerosis. J Am Soc Nephrol 1993;3:1775–82.
- Simons JL, Provoost AP, Anderson S, et al. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994;46:396–404.
- Van Rodijnen WF, van Lambalgen TA, Tangelder GJ, et al. Reduced reactivity of renal microvessels to pressure and angiotensin II in Fawn-Hooded rats. Hypertension 2002;39:111–5.
- Van Dokkum RP, Sun CW, Provoost AP, et al. Altered renal hemodynamics and impaired myogenic responses in the fawn-hooded rat. Am J Physiol 1999;276:R855–63.
- Simons JL, Provoost AP, De Keijzer MH, et al. Pathogenesis of glomerular injury in the fawn-hooded rat: effect of unilateral nephrectomy. J Am Soc Nephrol 1993;4:1362–70.
- Ochodnický P, Henning RH, Buikema HJ, et al. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat. Am J Physiol Renal Physiol 2010;298:F625–33.
- Pabbidi MR, Juncos J, Juncos L, et al. Identification of a region of rat chromosome 1 that impairs the myogenic response and autoregulation of cerebral blood flow in fawn-hooded hypertensive rats. Am J Physiol Heart Circ Physiol 2013;304:H311–7.
- Kunert MP, Dwinell MR, Lombard JH. Vascular responses in aortic rings of a consomic rat panel derived from the Fawn Hooded Hypertensive strain. Physiol Genomics 2010;42A:244–58.
- Verseput GH, Provoost AP, Braam BB, et al. Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat. J Am Soc Nephrol 1997;8(2):249–59.
- Verseput GH, Koomans HA, Braam B, et al. ACE inhibition delays development of terminal renal failure in the presence of severe albuminuria. Am J Kidney Dis 2000;35:202–10.
- Weichert W, Paliege A, Provoost AP, Bachmann S. Upregulation of juxtaglomerular NOS1 and COX-2 precedes glomerulosclerosis in fawn-hooded hypertensive rats. Am J Physiol Renal Physiol 2001;280:F706–14.
- Kuijpers MH, de Jong W. Relationship between blood pressure level, renal histopathological lesions and plasma renin activity in fawn-hooded rats. Br J Exp Pathol 1987;68:179–87.
- Honetschlägerová Z, Z Husková Z, Vaňourková Z, et al. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension. J Physiol 2011;589:207–19.
- Sporková A, Kopkan L, Varcabová S, et al. Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2011;300:R1468–75.
- Hošková L, Málek I, Kautzner J, et al. Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system. Hypertens Res 2014;37:724–32.
- OpenUrlKujal P, Čertíková Chábová V, Škaroupková P, et al. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clin Exp Pharmacol Physiol 2014;41:227–37.
- Kopkan L, Husková Z, Sporková A, et al. Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension. Kidney Blood Press Res 2012;35:595–607.
- Kopkan L, Kramer HJ, Husková Z, et al. The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats. J Hypertens 2005;23:1531–39.
- van Dokkum RP, Jacob HJ, Provoost AP. Blood pressure and the susceptibility to renal damage after unilateral nephrectomy and L-NAME-induced hypertension in rats. Nephrol Dial Transplant 2000;15:1337–43.
- Mattson DL, Dwinell MR, Greene AS, et al. Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats. Am J Physiol Renal Physiol 2007;293:F1905–14.
- Burke M, Pabbidi M, Fan F, et al. Genetic basis of the impaired renal myogenic response in FHH rats. Am J Physiol Renal Physiol 2013;304:F565–77.
- Baylis C. Sexual dimorphism of the aging kidney: role of nitric oxide deficiency. Physiology (Bethesda) 2008;23:142–50.
- Vavrinec P, Henning RH, Goris M, et al. Renal myogenic constriction protects the kidney from age-related hypertensive renal damage in the Fawn-Hooded rat. J Hypertens 2013;31:1637–45.
- Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 2005;289:F496–503.
- Bürgelová M, Vanourková Z, Thumová M, et al. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J Hypertens 2009;27:1988–2000.
- Liu CX, Hu Q, Wang Y, et al. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol Med 2011;17:59–69.
- Zimmerman D, Burns KD. Angiotensin-(1-7) in kidney disease: a review of the controversies. Clin Sci (Lond) 2012;123:333–46.